
ISPR Stock Forecast & Price Target
ISPR Analyst Ratings
Bulls say
Ispire Technology Inc. has demonstrated a robust financial performance, with revenue reaching $15.4 million, representing approximately a 30% year-over-year increase, primarily driven by strategic investments in its Malaysian facility and the submission of PMTA applications. The ongoing demand for the company’s e-cigarettes and cannabis vaping products is critical for sustaining growth and positive free cash flow. Additionally, regulatory developments, such as the FDA's recent focus on illicit vape shipments, may enhance market conditions in the U.S. and present new opportunities for Ispire's product offerings.
Bears say
Ispire Technology Inc. reported a significant decrease in revenue, with 2Q'25 figures of $26.2 million showing a decline of approximately 13% year-over-year and a stark 37% quarter-over-quarter drop, highlighting a troubling trend in sales performance. The company also faced a net income loss of $10.9 million, reflecting a continued negative financial trajectory compared to the previous year. Additionally, a gross margin (GM%) of 18.2%, alongside challenges such as tariff impacts and seasonality, indicates pressure on profitability that further compounds the company’s financial difficulties.
This aggregate rating is based on analysts' research of Ispire Technology Inc and is not a guaranteed prediction by Public.com or investment advice.
ISPR Analyst Forecast & Price Prediction
Start investing in ISPR
Order type
Buy in
Order amount
Est. shares
0 shares